{
    "code": "01021137",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01021137",
    "time": "2020-02-25 03:01:34",
    "許可證字號": "衛署藥製字第021137號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/10\/08",
    "註銷理由": "自請註銷",
    "有效日期": "103\/05\/25",
    "發證日期": "69\/03\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102113707",
    "中文品名": "抗疤能顆粒",
    "英文品名": "SCARTENAN GRANULES",
    "適應症": "預防皮膚傷漫延、促進傷口癒合、預防傷口癒合後結疤、瘢瘤、抽筋及萎縮、促進皮膚移植時的結合、增加皮膚自體移殖時的耐藥力、預防皮膚自體移植時重覆長新肉芽的現象、延遲骨折時傷口的硬化",
    "劑型": "150內服顆粒劑",
    "包裝": "袋裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "1310504200  葡萄王生技股份有限公司",
        "申請商地址": "中壢市龍岡路三段６０號",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8406000110",
            "成分名稱": "CALCIUM ACEXAMATE",
            "含量描述": "2500",
            "含量": "2500.0000000000",
            "單位": "MG"
        }
    ]
}